Overview Request Sample Pages Request Customization Download PDF
You are viewing: US Coagulation Analyzer Market analysis
Part of: Coagulation Analyzer Market (Global)

The US Coagulation Analyzer Market was valued at $459.1 Million in 2025 and projected to reach to $585.2 Million by 2030, representing a compound annual growth rate of 5.0%. The US coagulation analyzer market is positioned for steady growth through 2030, supported by an aging population requiring enhanced thrombotic risk management and anticoagulation monitoring.

US Coagulation Analyzer Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

US Coagulation Analyzer Market Trends and Insights

  • The US market benefits from advanced healthcare infrastructure, high adoption of automated diagnostic systems, and strong demand from hospitals and clinical laboratories.
  • Aging demographics and increased prevalence of bleeding disorders and cardiovascular diseases are driving demand for coagulation testing across the US healthcare system. In the US, coagulation analyzers are essential for monitoring anticoagulant therapy, diagnosing hemostatic disorders, and supporting surgical procedures.
  • The US market is characterized by the presence of leading diagnostic manufacturers and a well-established reimbursement framework that supports laboratory testing.
  • Between 2025 and 2030, the US market will experience steady growth driven by technological innovations, point-of-care testing expansion, and integration of artificial intelligence in diagnostic platforms..

Key Market Statistics

  • CAGR (2025-2030) 5.0% CAGR
  • Market Size, 2025 ~USD 459.1 Million
  • Forecast, 2030 ~USD 585.2 Million
  • Country US

US Coagulation Analyzer Market Overview

Market Size & Growth :

The US coagulation analyzer market is valued at $459.1 million in 2025 and is projected to reach $585.2 million by 2030, representing a steady 5.0% CAGR driven by technological advancements and increased diagnostic demand.

Advanced Healthcare Infrastructure :

The US benefits from a mature healthcare system with widespread adoption of automated diagnostic systems across hospitals, clinical laboratories, and point-of-care settings, supporting robust market expansion.

Aging Population Dynamics :

Rising geriatric demographics in the US correlate with increased prevalence of coagulation disorders, thrombotic events, and anticoagulation therapy monitoring, driving sustained demand for coagulation analyzers.

Regulatory & Reimbursement Environment :

Strong FDA oversight, favorable reimbursement policies from Medicare and private insurers, and established clinical guidelines support consistent adoption of coagulation testing technologies across US healthcare facilities.

US Coagulation Analyzer Market Dynamics

  • Hospitals and clinical laboratories continue to invest in automated, high-throughput systems that improve diagnostic accuracy and operational efficiency.
  • Technological innovations, including point-of-care testing devices and integrated laboratory information systems, are expanding market accessibility beyond traditional settings.
  • Reimbursement stability and clinical guideline adoption further reinforce market fundamentals.
  • However, growth remains moderate at 5.0% CAGR compared to global rates, reflecting market maturity and competitive consolidation among established diagnostic manufacturers..

Related Ecosystem

Analytical And Scientific Instrumentation

Top Technologies
  • Environmental Testing
  • Gas Chromatography
  • Polymerase Chain Reaction (PCR)
  • Automated Liquid Handling Systems
  • Flow Cytometry
Top Companies
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • Merck KGaA
  • Shimadzu Corporation

    Key Takeaways

    • The US coagulation analyzer market is valued at $459.1 million in 2025 and will reach $585.2 million by 2030, representing a 5.0% CAGR.
    • The US market is driven by aging population demographics, rising cardiovascular disease prevalence, and increased demand for anticoagulation monitoring.
    • Advanced healthcare infrastructure and strong reimbursement policies in the US support widespread adoption of automated coagulation testing systems.
    • Technological innovations including point-of-care testing and AI-integrated platforms are accelerating market growth in the US through 2030.

    Coagulation Analyzer Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment ANTI-FACTOR XA TESTS (Test)
    Forecast Period 2025–2030
    Growth Rate CAGR of 7.2% from 2025 to 2030
    Largest Segment CLINICAL LABORATORY ANALYZERS (Product)
    Market Size Base Year (Billions) ~USD 3.77 (2025)
    Revenue Forecast (Billions) ~USD 5.34 (2030)
    Segments Covered Product, Type, Test, Testing Site, Technology, End User, Site Of Testing

    US Coagulation Analyzer Market Report Segmentation

    7 segment dimensions are covered across the global market.

    By Product

    • Clinical Laboratory Analyzers
    • Point-Of-Care Testing Analyzers

    By Type

    • Automated Systems
    • Consumables
    • Manual Systems
    • Reagents
    • Semi-Automated Systems
    • Standards, Controls, And Calibrators
    • Systems

    By Test

    • Activated Clotting Time Testing
    • Activated Partial Thromboplastin Time Testing
    • Anti-Factor Xa Tests
    • D-Dimer Testing
    • Fibrinogen Testing
    • Heparin & Protamine Dose Response Tests For Act
    • Other Coagulation Tests
    • Platelet Function Tests
    • Prothrombin Time/International Normalized Ratio (Pt/Nr)

    By Testing Site

    • Laboratory Testing
    • Point-Of-Care Testing

    By Technology

    • Electrochemical Technology
    • Mechanical Technology
    • Optical Technology
    • Other Technologies

    By End User

    • Clinical Laboratories
    • Hospitals
    • Other End Users

    By Site Of Testing

    • Laboratory Testing
    • Point-Of-Care Testing

    US: COAGULATION ANALYZERS MARKET, BY END USER, 2022–2030

    Segment20222023202420252026202820292030CAGR (%)
    CLINICAL LABORATORIES249.8258.7268.6282.5295.5326.6342.7359.64.9
    HOSPITALS389.5407.7427.7454.6480.5542.2574.8609.36
    OTHER END USERS129.5134.7140.4148.3155.7173.5182.8192.65.4
    TOTAL768.8801.2836.8885.5931.71042.31100.31161.45.6

    Target Audience

    • In Vitro Diagnostics Manufacturers : Coagulation analyzer manufacturers need US-specific market data to assess market entry feasibility, competitive positioning, and revenue forecasting for product launches and portfolio expansion decisions.
    • Hospital & Laboratory Administrators : Healthcare facility leaders require market insights on technology trends, cost-benefit analyses, and adoption benchmarks to justify capital investments in coagulation testing infrastructure and optimize diagnostic operations.
    • Medical Device Investors & PE Firms : Investment professionals need comprehensive US market valuations, growth trajectories, and reimbursement dynamics to evaluate acquisition targets, fund allocation decisions, and portfolio company performance metrics.
    • Healthcare Consultants & Strategy Firms : Consulting professionals require detailed US market segmentation, demographic drivers, and competitive intelligence to advise clients on market entry strategies, product positioning, and operational optimization.
    • Regulatory & Compliance Officers : Compliance professionals need US-specific regulatory frameworks, reimbursement policies, and clinical guideline information to ensure product alignment with FDA requirements and insurance coverage criteria.

    Key Companies in the US Coagulation Analyzer Market

    CompanyHQOwnershipStrongest segments
    SYSMEX CORPORATIONJapan
    SIEMENS HEALTHINEERS AGGermany
    F. HOFFMANN-LA ROCHE LTD.United States
    THERMO FISHER SCIENTIFIC INC.United StatesPublic CompanyClinical Laboratory Analyzers,Consumables,Reagents,
    NIHON KOHDEN CORPORATIONJapanPublic CompanyClinical Laboratory Analyzers,Reagents,Consumables,
    BIOSYNEX SAFrancePublic CompanyClinical Laboratory Analyzers,Consumables,Reagents,
    ABBOTTUnited StatesPublic CompanyClinical Laboratory Analyzers,Consumables,Reagents,
    DANAHERUnited StatesPublic CompanyClinical Laboratory Analyzers,Consumables,Reagents,
    HORIBA, LTD.JapanPublic CompanyClinical Laboratory Analyzers,Reagents,Consumables,
    MACCURA BIOTECHNOLOGY CO., LTD.ChinaPublic CompanyClinical Laboratory Analyzers (Coagulation Systems),Consumables & Reagents (PT, APT, D-Dimer and related),Systems & Automation (integration, software, service),

    SYSMEX CORPORATION

    Sysmex Corporation is a Japanese diagnostics company manufacturing hematology, hemostasis, and urinalysis analyzers.

    SIEMENS HEALTHINEERS AG

    Siemens Healthineers AG is a German medical technology company offering diagnostic imaging, laboratory diagnostics, and point-of-care solutions.

    F. HOFFMANN-LA ROCHE LTD.

    F. Hoffmann-La Roche Ltd. is a Swiss pharmaceutical and diagnostics company developing medicines, vaccines, and in vitro diagnostic tests.

    THERMO FISHER SCIENTIFIC INC.

    Thermo Fisher Scientific Inc. is a leading provider of laboratory equipment, reagents, and services for research, diagnostics, and bioproduction, founded in 1956 with approximately 125,000 employees.

    NIHON KOHDEN CORPORATION

    Nihon Kohden Corporation is a Japanese medical device manufacturer specializing in patient monitoring, diagnostic imaging, and clinical laboratory equipment, founded in 1951 with 6,116 employees.

    BIOSYNEX SA

    Biosynex SA is a French in vitro diagnostics company founded in 2005, publicly traded with 397 employees specializing in rapid diagnostic tests.

    ABBOTT

    Abbott is a diversified U.S. healthcare company founded in 1888 with approximately 115,000 employees, providing pharmaceuticals, diagnostics, nutritional products, and medical devices.

    DANAHER

    Danaher is a U.S. conglomerate founded in 1969 with 59,000 employees operating across diagnostics, life sciences, environmental, and industrial segments.

    HORIBA, LTD.

    Horiba, Ltd. is a Japanese public company founded in 1945 with 9,101 employees manufacturing analytical and measurement instruments for automotive, medical, and environmental applications.

    MACCURA BIOTECHNOLOGY CO., LTD.

    Maccura Biotechnology Co., Ltd. is a Chinese diagnostics company founded in 1994 with 2,875 employees producing clinical laboratory analyzers and reagents.

    Reasons to Buy this Report

    • Market Size & Valuation Data : Access precise US market valuation ($459.1M in 2025) and 5-year forecast projections to benchmark competitive positioning and identify revenue opportunities in a $585.2M market by 2030.
    • Demographic & Clinical Insights : Understand aging population trends and increased prevalence of coagulation disorders driving demand for analyzers, enabling targeted product development and market penetration strategies specific to US patient demographics.
    • Healthcare Infrastructure Analysis : Gain detailed intelligence on US hospital networks, clinical laboratory adoption rates, and point-of-care settings to optimize distribution channels and identify high-growth facility segments.
    • Regulatory & Reimbursement Framework : Navigate FDA approval pathways, Medicare/insurance reimbursement policies, and clinical guidelines specific to the US market to accelerate product launches and ensure commercial viability.
    • Competitive Landscape Assessment : Evaluate market consolidation trends, key player strategies, and technology differentiation opportunities within the US market to inform go-to-market planning and partnership development.

    Frequently asked questions

    What is the current size of the US coagulation analyzer market?

    The US coagulation analyzer market is valued at $459.1 million in 2025 and is expected to grow to $585.2 million by 2030.

    What is the growth rate of the US coagulation analyzer market?

    The US coagulation analyzer market is growing at a compound annual growth rate (CAGR) of 5.0% from 2025 to 2030.

    What factors are driving growth in the US coagulation analyzer market?

    Key drivers include an aging population, rising prevalence of cardiovascular diseases, increased anticoagulation therapy monitoring, technological innovations, and strong healthcare infrastructure with favorable reimbursement policies.

    Which segments dominate the US coagulation analyzer market?

    Hospital laboratories and clinical diagnostic centers represent the largest segments in the US market, followed by point-of-care testing facilities and specialty anticoagulation clinics.

    What technological trends are shaping the US coagulation analyzer market?

    Key trends include the adoption of automated high-throughput analyzers, point-of-care testing devices, artificial intelligence integration for result interpretation, and connectivity features for laboratory information systems.

    RESEARCH METHODOLOGY

    This study extensively utilized both primary and secondary sources. Initially, secondary research methods were employed to gather data about the market, including its parent and peer markets. The next phase involved conducting primary research to validate these conclusions and assumptions by engaging with industry experts throughout the value chain. A combination of top-down and bottom-up approaches was applied to assess the overall market size. Subsequently, the market sizes of segments and subsegments were estimated using data triangulation techniques and market breakdown analysis.

    Secondary Research

    The secondary research process extensively utilizes a variety of secondary sources, including directories and databases such as Bloomberg Business, Factiva, and D&B Hoovers. It incorporates white papers, annual reports, investor presentations, and SEC filings from companies, along with publications from government bodies like the National Institutes of Health (NIH), the US Food and Drug Administration (FDA), the US Census Bureau, the World Health Organization (WHO), the International Trade Administration (ITA), the International Society on Thrombosis and Haemostasis (ISTH), the European Hematology Association (EHA), and the World Federation of Hemophilia (WFH). These resources were accessed to gather and analyze information for the global coagulation analyzers market study. The research aimed to identify key players in the market, categorize and segment the information according to industry trends, and capture important developments related to the market and technology perspectives. Additionally, a database of leading industry figures was created using secondary research.

    Primary Research

    In the primary research process, various sources from both the supply and demand sides were interviewed to gather qualitative and quantitative information for this report. The primary sources from the supply side included industry experts such as CEOs, vice presidents, marketing and sales directors, technology and innovation directors, and other key executives from important companies and organizations in the coagulation analyzers market. On the demand side, primary sources included hospitals, clinical laboratories, and other end users. This primary research was conducted to validate market segmentation, identify key players, and collect insights on significant industry trends and market dynamics.

    A breakdown of the primary respondents is provided below:

    Coagulation Analyzers Market

    Note 1: C-level executives include CEOs, CFOs, COOs, and VPs.

    Note 2: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

    Note 3: Tiers are defined based on a company’s total revenue. As of 2024, Tier 1= >USD 10 billion, Tier 2 = USD 1 billion to USD 10 billion, and Tier 3 = < USD 1 billion.

    Source: MarketsandMarkets Analysis

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Annual revenues were calculated based on revenue data from major product manufacturers and OEMs involved in the global coagulation analyzers market to determine the global market value. Key manufacturers were identified at both the global and regional levels. Revenue mapping for their respective business segments and subsegments was conducted for these leading players.

    The global coagulation analyzers market was categorized into various segments and subsegments based on the following criteria:

    • A list of major players operating in the product market at the regional and country levels.
    • Product mapping of various coagulation analyzer manufacturers at the regional and country levels.
    • Mapping of annual revenues generated by the listed major players, specifically from coagulation analyzers or related business units/products.
    • Extrapolation of the revenue data from these major players to estimate the global market value for the respective segments and subsegments.
    • Summation of the market values of all segments and subsegments to establish the total value of the global coagulation analyzers market.

    This data was consolidated, along with detailed inputs and analysis from MarketsandMarkets, and presented in this report.

    Market Size Estimation (Bottom-up Approach & Top-down Approach)

    Coagulation Analyzers Market

    Data Triangulation

    After arriving at the overall size of the global coagulation analyzers market through the above-mentioned methodology, this market was split into several segments and subsegments. Where applicable, the data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact market value data for the key segments and subsegments. Examining several macrovariables and regional trends from demand- and supply-side players helped triangulate the extrapolated market data.

    Market Definition

    A coagulation analyzer is an important medical diagnostic tool that checks how well blood can clot by measuring several key factors, including prothrombin time (PT), activated partial thromboplastin time (aPTT), thrombin time (TT), and fibrinogen levels. This device plays a crucial role in diagnosing bleeding disorders like hemophilia, monitoring anticoagulant therapies with drugs such as aspirin, heparin, or warfarin, and managing patients during surgeries. Coagulation analyzers provide fast and accurate evaluations of clotting efficiency and platelet counts, which helps healthcare providers make quick clinical decisions in both hospital and lab environments.

    Stakeholders

    • Coagulation analyzer instrument manufacturers
    • Coagulation analyzer reagent manufacturers
    • Group purchasing organizations (GPOs)
    • Original equipment manufacturers (OEMs)
    • Pharmaceutical & biotechnology companies
    • Academic research institutes related to coagulation studies
    • Venture capitalists and investors
    • Healthcare facilities (hospitals, clinical laboratories, and other end users)
    • Research & consulting firms
    • Research institutes

    Report Objectives

    • To define, describe, and forecast the coagulation analyzers market based on product, test, technology, end user, and region
    • To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and industry-specific challenges)
    • To assess the coagulation analyzers market with respect to Porter’s Five Forces, regulatory landscape, the value chain, the supply chain, patent analysis, pricing assessment, key stakeholders, and buying criteria
    • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
    • To analyze the opportunities in the coagulation analyzers market for stakeholders and provide details of the competitive landscape for market leaders
    • To forecast the size of the coagulation analyzers market in five primary regions (along with countries): North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
    • To profile the key players operating in the coagulation analyzers market and comprehensively analyze their core competencies and market shares
    • To track and analyze competitive developments such as partnerships, agreements, collaborations, acquisitions, expansions, product/technology developments, and product approvals
    • To benchmark players within the coagulation analyzers market using the Company Evaluation Matrix framework, which analyzes market players on various parameters within categories of business strategies, market share, and product offerings
    • To understand the impact of AI/generative AI on the market

     

    Get the Full Coagulation Analyzer Market Report

    Full forecast, segment splits, and company analysis for all Coagulation Analyzer Market.

    Download Sample Pages Buy Report

    METHODOLOGY

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    Cite this Research
    DMCA.com Protection Status